Marshall Wace North America’s Lydall, Inc. LDL Stock Holding History
Bought
Maintained
Sold
Other funds holding LDL
CIP
ICOM
Marshall Wace North America's LDL Position: Q4 2017 in Review
Marshall Wace North America sold out of Lydall, Inc. (LDL) in Q4 2017, closing a stake of 39,918 shares — an estimated $2.27M sold.
Marshall Wace North America first reported a position in LDL in Q2 2017 and held it in 2 quarters. The position peaked at $2.27M in Q3 2017. 161 funds tracked by Wall St. Rank hold LDL as of Q4 2017.
- Marshall Wace North America reported no remaining Lydall, Inc. position as of Q4 2017 after selling out during the quarter.
- Marshall Wace North America sold 39,918 Lydall, Inc. shares in Q4 2017, an estimated $2.27M.
- Marshall Wace North America first reported a position in Lydall, Inc. in Q2 2017 and held it in 2 quarters.
- Marshall Wace North America's Lydall, Inc. position peaked at $2.27M in Q3 2017.
- 161 funds tracked by Wall St. Rank held Lydall, Inc. as of Q4 2017.
Based on Marshall Wace North America's 13F filing for Q4 2017, filed 14 Feb 2018.